Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat-Reference-Cited by-同舟云学术

Unilateral axonal or terminal injection of 6-hydroxydopamine causes rapid-onset nigrostriatal degeneration and contralateral motor impairments in the rat

Published:2008-11 Issue:5 Volume:77 Page:312-319
ISSN:0361-9230
Container-title:Brain Research Bulletin
language:en
Short-container-title:Brain Research Bulletin

Author:

Grealish Shane,Xie Lan,Kelly Maebh,Dowd Eilís

Publisher

Elsevier BV

Subject

General Neuroscience

Reference29 articles.

1. Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats.;Berger;Brain Res. Bull.,1991

2. Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model;Blandini;Eur J. Neurosci.,2007

3. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons;Bowenkamp;J. Comp. Neurol.,1995

4. Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen;Cadet;Brain Res. Bull.,1991

5. Modeling Parkinson’s disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway;Deumens;Exp. Neurol.,2002

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequential or Simultaneous Injection of Preformed Fibrils and AAV Overexpression of Alpha-Synuclein Are Equipotent in Producing Relevant Pathology and Behavioral Deficits;Journal of Parkinson's Disease;2022-05-24

2. Neuropsychiatric and Cognitive Deficits in Parkinson’s Disease and Their Modeling in Rodents;Biomedicines;2021-06-17

3. Comparison between Tail Suspension Swing Test and Standard Rotation Test in Revealing Early Motor Behavioral Changes and Neurodegeneration in 6-OHDA Hemiparkinsonian Rats;International Journal of Molecular Sciences;2020-04-20

4. Experimental animal models of Parkinson's disease: A transition from assessing symptomatology to α-synuclein targeted disease modification;Experimental Neurology;2017-12

5. Inverse Expression Levels of EphrinA3 and EphrinA5 Contribute to Dopaminergic Differentiation of Human SH-SY5Y Cells;Journal of Molecular Neuroscience;2016-05-23